Debra K Farver Selected Research

Debra K Farver Research Topics

1	Seizures (Absence Seizure) 01/2017
1	Pancreatic Neoplasms (Pancreatic Cancer) 02/2012
1	Restless Legs Syndrome (Restless Legs) 02/2012
1	Heart Failure 07/2010
1	Atrial Fibrillation 07/2010
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2010
1	Dyslipidemias (Dyslipidemia) 01/2010
1	Sleep Initiation and Maintenance Disorders (Insomnia) 09/2009
1	Narcolepsy 03/2006
1	Nausea 03/2006
1	Pain (Aches) 03/2006
1	Sleepiness 03/2006
1	Dizziness (Lightheadedness) 03/2006
1	Headache (Headaches) 03/2006
1	Cataplexy 03/2006
1	Disorders of Excessive Somnolence (Hypersomnia) 03/2006
1	Diarrhea 05/2005
1	Neuroleptic Malignant Syndrome 01/2003
1	Disease Progression 01/2003

2	Pharmaceutical PreparationsIBA 09/2009 - 03/2006
1	Levetiracetam (Keppra)FDA LinkGeneric 01/2017
1	brivaracetamIBA 01/2017
1	1- (((alpha- isobutanoyloxyethoxy)carbonyl)aminomethyl)- 1- cyclohexaneacetic acidIBA 02/2012
1	Dronedarone FDA Link 07/2010
1	fenofibric acid FDA Link 01/2010
1	oxidized low density lipoproteinIBA 01/2010
1	Rosuvastatin Calcium (Crestor)FDA Link 01/2010
1	CholesterolIBA 01/2010
1	Coenzyme A (CoA)IBA 01/2010
1	LipidsIBA 01/2010
1	HDL CholesterolIBA 01/2010
1	LDL CholesterolIBA 01/2010
1	Oxidoreductases (Dehydrogenase)IBA 01/2010
1	Fenofibrate (CiL)FDA LinkGeneric 01/2010
1	Triglycerides (Triacylglycerol)IBA 01/2010
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2010
1	gamma-Aminobutyric Acid (GABA)IBA 09/2009
1	GABA Agonists (GABA Receptor Agonists)IBA 09/2009
1	indiplonIBA 09/2009
1	Sodium Oxybate (gamma Hydroxybutyrate)FDA Link 03/2006
1	ramoplaninIBA 05/2005
1	Antipsychotic Agents (Antipsychotics)IBA 01/2003

2	Therapeutics 01/2017 - 01/2010
1	Oral Administration 05/2005